
APIMEDS PHARMACEUTICALS US I
APUSNYSE AMERICAN๐ #4270 by market capUS Equity
$4.63โฒ $0.43 (+9.20%)
๐
Pre-market$4.63โฒ 0.00%Regular close ยท extended-hours price shown1hโ
24hโฒ 9.2%
7dโผ 3.5%
14dโผ 19.8%
30dโผ 36.5%
1yโผ 70.7%
๐ฆMarket Cap
$7M
Small Cap
๐Revenue Growth (YoY)
+0.0%
Slowing
๐Gross Margin
0.0%
Thin
๐ตFCF Margin
0.0%
Thin
โ๏ธP/S Ratio
0.0x
Cheap
Otter Score
54
Weak
Earnings
Q2 ยท 2026Reported 2026-05-26Earnings Per Share
Actual
-22.60
Expected
โ
โ
โ
YoY โ6394.30%
Revenue
Actual
โ
Expected
โ
โ
โ
Consensus estimates
Recent quarters
Q2 2026
-22.60
โ
Q4 2025
-0.14
โ
Q3 2025
-0.26
โ
Q2 2025
-0.35
โ